Clinical Trials Browser

Phase 2/3 × INDUSTRY × Liver Neoplasms × Clear all

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03592706 2020-04-16

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Phase 2/3 Unknown

60 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

67 enrolled

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00034333 2005-06-24

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Phase 2/3 Terminated

240 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00057382 2005-06-24

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Phase 2/3 Terminated

750 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Clinical Trials

ALIVE

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients